Poliomyelitis
📧 Sign up to get email alerts when something new happens for Poliomyelitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants [Phase 3]
Phase 3 trial comparing DTaP-IPV-HB-PRP-T (Sanofi Pasteur) to Infanrix Hexa when co-administered with Prevnar in Thai infants; results were …
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma) [Phase 2]
Phase 2 trial evaluating immunogenicity and safety of Trivalent OPV (tOPV Bio Farma) in healthy participants. The study has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Safety and Immunogenicity of a New Inactivated Poliovirus Vaccine in Infants [Phase 1, Phase 2]
Phase 1/2 trial updates indicate safety and immunogenicity of a new inactivated poliovirus vaccine in infants.
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults [Phase 1]
A Phase 1 trial evaluating safety and immunogenicity of a new inactivated polio vaccine in healthy adults has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule [Phase 3]
Phase 3 trial assessing the immunogenicity of a combined DTaP-IPV-Hep B-PRP~T vaccine versus PENTAXIM and ENGERIX B in infants at 2- to 4-mo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly [Phase 2]
This Phase 2 trial assesses immunogenicity and safety of a fractional intradermal booster dose of the inactivated poliovirus vaccine (IPV) c…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly [Phase 2]
Phase II trial evaluating immunogenicity and safety of fractional intradermal doses versus full intramuscular doses of inactivated polioviru…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV [Phase 3]
A Phase 3 study evaluating the immunogenicity and safety of Imovax Polio in Chinese infants compared with local oral poliovirus vaccine has …
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Safety of Imovax Polio in Chinese Infants and Children [Phase 3]
A Phase 3 trial evaluating the safety of Imovax Polio in Chinese infants and children has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi. [Phase 4]
Phase 4 clinical trial in Karachi evaluated the immune response to the inactivated poliovirus vaccine in malnourished infants compared with …
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Polio NID and Routine EPI Integration Trial Pakistan [NA]
A completed clinical trial in Pakistan evaluating the integration of National Immunization Days with the routine polio immunization program.
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Immunogenicity of Inactivated and Live Polio Vaccines [Phase 3]
Phase 3 trial update reporting immunogenicity data for inactivated and live poliovirus vaccines.
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia [Phase 4]
Phase 4 trial assessing safety of co-administration of GSK Poliorix and Infanrix in healthy children in Russia; completed with results poste…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants [Phase 2]
Phase 2 trial comparing a DTaP-IPV-Hep B-PRP~T combined vaccine with PENTAXIM and ENGERIX B in Argentinean infants has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns [Phase 3]
A Phase 3 randomized clinical trial is evaluating immunogenicity and safety in newborns in Mexico for poliomyelitis; the current status is u…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ [Phase 3]
Phase 3 study evaluating a combined DTaP-IPV-HepB-PRP-T vaccine given after a primary series of DTaP-IPV-HepB-PRP-T or Infanrix Hexa; result…
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Evaluation of Buffer on Immune Response to Oral Polio Vaccine (OPV) in Bangladesh [NA]
A completed Johns Hopkins trial in Bangladesh evaluated whether using a buffer can enhance the immune response to the oral polio vaccine.
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine [Phase 3]
Phase 3 trial update on the immunogenicity and safety of Infanrix-IPV+Hib vaccine from GlaxoSmithKline, completed with posted results in 201…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan [Phase 3]
Sanofi Pasteur's SP059 poliovirus vaccine candidate was studied in a three-dose primary plus booster schedule in infants in Japan, and the P…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China [Phase 4]
Phase 4 clinical trial assessing the safety of the PENTAXIM pentavalent vaccine given as a three-dose primary series at 2, 3, and 4 months o…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China [Phase 4]
The document reports the completion of a Phase 4 safety study of the IMOVAX Polio Vaccine in selected cities in China.
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants [Phase 3]
A Phase 3 immunogenicity study evaluating antibody persistence and booster response of the Pentaxim vaccine in healthy Argentinean infants; …
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine [Phase 3]
Phase 3 trial evaluating the safety and immunogenicity of a serum-free DTaP-IPVvero combination vaccine, completed with results reported by …
-
CLINICAL_TRIALS trial_result · 2012-11-26Clinical Trial Update: Immunogenicity and Safety of Adacel Polio Vaccine [Phase 3]
Phase 3 trial results summarize the immunogenicity and safety of Adacel Polio Vaccine; the study is completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: A Study of the Safety of IMOVAX Polio™ in China [Phase 4]
A Phase 4 safety study of IMOVAX Polio conducted in China has completed. The trial was sponsored by Sanofi.